MENU
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster


All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

NOV 5, 2020 Opens: 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Opioid Crisis 2020

LabRoots is pleased to announce the 1st Annual Opioid Crisis Virtual Event taking place on November 5th, 2020. The Opioid epidemic has been called the worst drug crisis in American history.  Join us as we discuss and exchange thoughts on the rise, spread, and control of Opioids.

Opioids are chemicals that bind to receptors in the brain and body associated with pain, reward, and addictive behaviors. Opioid medications are used by healthcare providers to relieve pain that cannot be treated with less powerful drugs. Common opioids include heroin and narcotic medications such as oxycodone, buprenorphine, morphine, codeine, methadone, and fentanyl. Opioid-related disorders are associated with overuse, misuse, and dependence on these drugs, and they include opioid-use disorder, opioid intoxication, and opioid withdrawal. 

This years event will include the following tracks:

  • Medications for Opioid Use Disorder  
  • Stigma Surrounding Opioid Use Disorder
  • Informatics and Opioid Stewardship
  • Health System Delivery of Opioid Use Disorder Treatment

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

This event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.



Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Opioid Crisis Virtual Event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.

Use #LRopioids to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Please join us for this FREE workshop, as we present Agilent’s LC/MS hardware and software solutions for getting the most out of your analysis data....
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 10, 2020 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models. Learn how to conduct modern cell-based assays with var...
OCT 29, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
OCT 29, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
The ICIS Annual Meetings typically attract 650-750 registrants and have a distinguished history of presenting cutting edge research from internationally recognized scientists. This meeting e...
Agenda
Scheduled
  • Keynote Presentation: The Opioid Crisis: Made in America...Fade in America
    NOV 05, 2020 7:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: The Opioid Crisis: Made in America...Fade in America
    Professor Bertha Madras (the Honorable)
    McLean Hospital and Harvard Medical School
  • NOV 05, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Panel Presentation: The NIH HEAL Initiative: A Bold Interagency Response to the Opioid Crisis
    Rebecca G. Baker, PhD
    Director, NIH HEAL Initiative, Office of the Director,...
    Linda L. Porter, PhD
    Director, Office of Pain Policy, National Institute of...
    Jack B. Stein, PhD
    Director, Office of Science Policy and Communications;...
The following webinars will be readily on-demand when the event starts
  • Buprenorphine Induction Strategies
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Buprenorphine Induction Strategies
    Jennifer Ball, PharmD, BCACP, BCGP
    Associate Professor, Pharmacy Practice, South Dakota State University
  • MAT's Not For Me: Addressing Stigma Toward MAT within the Recovery Community
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    MAT's Not For Me: Addressing Stigma Toward MAT within the Recovery Community
    Glenn E. Sterner III, PhD
    Assistant Professor of Criminal Justice, Criminal Justice Research Center, The Pennsylvania State University
  • Stigma and Substance Use: Evidence and Myths
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Stigma and Substance Use: Evidence and Myths
    Thomas S. Franko, PharmD, BCACP
    Associate Professor Pharmacy Practice, Wilkes University
  • The importance of educating patients and their physicians on opioid use: lessons learned from medical cases
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The importance of educating patients and their physicians on opioid use: lessons learned from medical cases
    Alan H.B. Wu, PhD, DABACC
    Chief of Clinical Chemistry and Toxicology Medical Director, Pharmacogenomics Laboratory San Francisco General Hospital Professor of Laboratory Medicine, USF
  • Medications for opioid use disorder
  • Buprenorphine Induction Strategies
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Buprenorphine Induction Strategies
    Jennifer Ball, PharmD, BCACP, BCGP
    Associate Professor, Pharmacy Practice, South Dakota State University
  • Health system delivery of opioid use disorder treatment
  • The importance of educating patients and their physicians on opioid use: lessons learned from medical cases
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The importance of educating patients and their physicians on opioid use: lessons learned from medical cases
    Alan H.B. Wu, PhD, DABACC
    Chief of Clinical Chemistry and Toxicology Medical Director, Pharmacogenomics Laboratory San Francisco General Hospital Professor of Laboratory Medicine, USF
  • NOV 05, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Panel Presentation: The NIH HEAL Initiative: A Bold Interagency Response to the Opioid Crisis
    Rebecca G. Baker, PhD
    Director, NIH HEAL Initiative, Office of the Director,...
    Linda L. Porter, PhD
    Director, Office of Pain Policy, National Institute of...
    Jack B. Stein, PhD
    Director, Office of Science Policy and Communications;...
  • Stigma surrounding opioid use disorder
  • MAT's Not For Me: Addressing Stigma Toward MAT within the Recovery Community
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    MAT's Not For Me: Addressing Stigma Toward MAT within the Recovery Community
    Glenn E. Sterner III, PhD
    Assistant Professor of Criminal Justice, Criminal Justice Research Center, The Pennsylvania State University
  • Stigma and Substance Use: Evidence and Myths
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Stigma and Substance Use: Evidence and Myths
    Thomas S. Franko, PharmD, BCACP
    Associate Professor Pharmacy Practice, Wilkes University
  • Keynote Presentation: The Opioid Crisis: Made in America...Fade in America
    NOV 05, 2020 7:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: The Opioid Crisis: Made in America...Fade in America
    Professor Bertha Madras (the Honorable)
    McLean Hospital and Harvard Medical School
Speakers

  • Rebecca G. Baker, PhD
    Director, NIH HEAL Initiative, Office of the Director, National Institutes of Health
    Biography

      Rebecca G. Baker, Ph.D., is the director of the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, in the Office of the Director, NIH. Dr. Baker helped develop the NIH HEAL Initiative and leads coordination of HEAL programmatic activities between the Office of the Director and relevant Institutes and Centers (ICs), NIH HEAL Initiative staff, and governance committees. She also provides expert advice to and represents the NIH Director on initiative-related activities, including interagency efforts and partnerships in pain and opioid research and policy. Prior to holding this position, Dr. Baker was special assistant to the NIH Director, working directly with NIH leadership to develop new scientific initiatives, and analyze scientific, legislative, communications, and policy issues. Previously, she worked as a postdoctoral scientist using next-generation DNA sequencing to identify novel disease-causing genes in patients with rare immunological diseases. She earned her Ph.D. from the University of Pennsylvania and her bachelor's degree from Cornell University.

    • Jennifer Ball, PharmD, BCACP, BCGP
      Associate Professor, Pharmacy Practice, South Dakota State University
      Biography

        Jennifer Ball is an associate professor of pharmacy practice at South Dakota State University.  She practices in ambulatory care with a focus in substance use disorders and women’s health at the Center for Family Medicine as faculty within the Sioux Falls Family Medicine Residency Program and Pierre Rural Family Medicine Residency Program.  Within her clinical and education role, Jennifer practices as part of an interdisciplinary substance use disorders treatment team and provides statewide education as a hub expert in Avera Project ECHO: Substance Use, Mental Health, and MAT.  Her role in substance use disorders training has awarded her several State Opioid Response (SOR) and Rural Communities Opioid Response Program (RCORP) grants to expand treatment, healthcare professional training, and networking across the state of South Dakota.

      • Professor Bertha Madras (the Honorable)
        McLean Hospital and Harvard Medical School
        Biography

          Current position. Professor of Psychobiology, Harvard Medical School (34 years) with office based at McLean Hospital Belmont, MA and cross-appointment at the Massachusetts General Hospital. Educated at McGill University, Montreal; post-doctoral fellow MIT.

          Translational Research. Addictive and therapeutic drugs: behavioral, molecular responses. Drug discovery. Novel brain probes, candidate therapeutics for neuropsychiatric disorders

          Authorship.  Author of over 200 scientific manuscripts, articles, book chapters, co-editor of books “The Cell Biology of Addiction”, “Effects of Drug Abuse on the Human Nervous System”, “Imaging of the Human Brain in Health and Disease”. 

          Inventions.  19 U.S. and 27 international patents, with collaborators.

          Government service and public policy. Numerous NIH committees and other advisory boards

          • White House, 2006-2008: Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP), Executive Office of the President, a presidential appointment confirmed unanimously (99-0) by U.S. Senate.
          • White House, 2017:  Appointed by the President, as one of six members of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Governors C. Christie, C. Baker, R. Cooper, Cong. P. Kennedy, AG P. Bondi). At request of Commission Chair Gov. Christie, she shepherded and wrote majority of the final Commission report.
          • World Health Organization: Sole author of a commissioned report, “Update of Cannabis and its Medical Use”; co-author of “The Health and Social Effects of Nonmedical Cannabis Use”.
          • U.S. Department of Justice: Sole expert witness for the U.S. Dept. of Justice in a landmark Federal Court decision on marijuana re-, or de-scheduling. DoJ position sustained.
          • Vatican Pontifical Academy of Sciences, Narcotics Panel: Co-author, edited final statement.
          • National Academy of Medicine: Current member, National Academy of Medicine Collaborative on the Opioid Crisis.

          Educator, Public Service. Over 300 presentations to students, public, professionals

          • Developed the first addictions course (elective) at Harvard Medical School; first NIDA-sponsored international course on Cell Biology of Addictions at Cold Spring Harbor Laboratory.
          • Museum exhibition: Project Director of NIDA-sponsored project, exhibit, CD, play at Museum of Science, Boston “Changing your Mind: Drugs in the Brain”. CD licensed to Disney Corp.

          Recognition

          • Research Awards: NIH MERIT award, CPDD Innovator Award, McLean Mendelson award, The Better World Report cited her brain imaging invention as “one of 25 technology transfer innovations (university to industry) that changed the world”. Public Service Awards: NIDA, CADCA, CPDD, Sweden, American Academy of Addiction Psychiatry Founders’ Award, others.

          Her experiences in research, brain biology, education, government and public service offer her a unique perspective on public policy, brain science and public education.

        • Thomas S. Franko, PharmD, BCACP
          Associate Professor Pharmacy Practice, Wilkes University
          Biography

            Dr. Franko is a 2011 graduate of the Philadelphia College of Pharmacy.  He completed a PGY1 residency at the Wilkes-Barre Veteran’s Affairs Medical Center.  After residency he developed the first pharmacist run medication therapy management clinic focused on chronic non-cancer pain in the region at Geisinger Medical Center in Danville, PA.  Dr. Franko joined the faculty at Wilkes University in 2013 with a focus in pain management and substance use disorder.  While at Wilkes Dr. Franko authored several papers on innovative education methodologies for pain management, opioid use, and pharmacist involvement with naloxone.  He has developed a pain and addiction elective course, and a substance use disorder practice lab focused on naloxone administration and SBIRT.  He is the advisor for the Wilkes chapter of Rho Chi, Generation Rx, and the faculty liaison for SARPH, the pharmacist recovery program for Pennsylvania.  He has presented several hours of continuing education on pain and substance use disorder issues on the state and national level.  Dr. Franko serves on several local, state and national committees aimed to enhance professional and public education on substance use disorder.  Current positions include Coordinator Elect for the Pain, Palliative Care, and Addiction Special Interest Group for the American Pharmacists Association, Region Two Councilor for Rho Chi, and President-Elect of the Pennsylvania Pharmacists Association.  Dr. Franko was named a Cardinal Health Generation Rx Champion for Pennsylvania in 2018 and was the lead author for the Pennsylvania Controlled Substance Dispensing Guidelines.

          • Linda L. Porter, PhD
            Director, Office of Pain Policy, National Institute of Neurological Disorders and Stroke
            Biography

              Dr. Linda Porter directs the National Institutes of Health’s Office of Pain Policy and Planning. She holds a bachelor’s degree in Physical Therapy from McGill University and a Ph.D. in Neuroscience from Boston University. Dr. Porter trained in neurophysiology at Rockefeller University and then served on the   faculty of the Uniformed Services University, where she directed a research program on sensory-motor integration. Dr. Porter joined the NIH in 2003 where her role includes coordinating activities of the NIH Pain Consortium and the Interagency Pain Research Coordinating Committee, whose missions respectively, are to advance the trans-NIH and interagency pain research agenda. She co-chaired the development of the National Pain Strategy and the Federal Pain Research Strategy and now is involved with the NIH HEAL (Helping End Addiction Long-term) initiative. Dr. Porter has been recognized for her work through the President’s Award from the American Academy of Pain Management, NIH Director’s Awards, and the Emma and John Bonica Public Service Award from the American Pain Society.

            • Jack B. Stein, PhD
              Director, Office of Science Policy and Communications; Chief of Staff, National Institute on Drug Abuse
              Biography

                Jack B. Stein, Ph.D. has over two decades of professional experience in leading national drug and HIV-related research, practice, and policy. He first joined NIDA as the OSPC Deputy Director, and later as the Deputy Director for the Division of Epidemiology, Services and Prevention Research. He then left NIDA to become Director of the Division of Services Improvement, Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration. Immediately prior to rejoining NIDA, Dr. Stein served as the Chief of the Prevention Branch, Office of Demand Reduction, at the White House Office of National Drug Control Policy. Dr. Stein has authored numerous articles, book chapters, and reports on HIV prevention and substance use services. He is a graduate of Union College, where he earned a bachelor of science in biology. He holds a master’s degree in social work from New York University and a doctoral degree in health services from Walden University.

              • Glenn E. Sterner III, PhD
                Assistant Professor of Criminal Justice, Criminal Justice Research Center, The Pennsylvania State University
                Biography

                  Dr. Glenn Sterner is an Assistant Professor of Criminal Justice at The Pennsylvania State University, Abington Campus. He serves as the coordinator of the Criminal Justice Research Center’s Greater Philadelphia Office for the University. As an expert on the opioid epidemic, he sits on the Opioid Overdose Task Force for the State of Pennsylvania.  He is also a founding member of the Penn State Consortium to Combat Substance Abuse advisory board.  He serves as a faculty fellow of the Penn State University Administrative Data Accelerator. He is the founder of the Share Your Opioid Story initiative, found at www.shareyouropioidstory.com. His main research agenda is focused on the application of social network analysis in understanding illicit, illegal, and covert networks, and he is experienced with both quantitative and qualitative research methodologies. Dr. Sterner has been awarded over $6.7 Million in local, state, and federal grants to study and address the opioid epidemic, including funding from the National Institute of Justice, Department of Justice, and the Substance Abuse and Mental Health Services Administration (SAMHSA).   His work includes the examination of opioid abuse networks, illegal opiate distribution, networks of legitimate opioid distributors and overdose deaths, hot spots of opioid availability, intelligence-based interventions in rural areas, and stigma associated with opioid and other substance use disorders. Dr. Sterner has presented his work locally, nationally, and internationally to organizations including opioid treatment and support organizations, Centre County HOPE, The Bucks County Together We Can Convention, Penn State Extension Annual Conference, The Wolf Administration’s Opioid Command Center, Georgia Pacific Company, The Federal Reserve Bank of Philadelphia, The American Society of Criminology, The Stockholm Criminology Symposium, and the International Network of Social Network Analysts.  His writings on this topic have been featured by the Department of Justice, The Hill, The Independence Blue Cross Foundation, and The National Prevention Science Coalition for Improving Lives, and peer reviewed journals including Substance Use and Misuse. Dr. Sterner collaborates extensively with law enforcement agencies on the local, state, and federal level in his work to address the opioid crisis and other substance use issues.  He has several active grants with the Pennsylvania State Police, and partners with local district attorneys, coroners, and police departments.  Within the Pennsylvania State Police, he regularly works with individuals in the Pennsylvania Criminal Intelligence Center (PaCIC), the data fusion center at State Police Headquarters in Harrisburg.  He has relationships within the Pennsylvania Attorney General’s Bureau of Narcotics Division, the Liberty Mid-Atlantic High Intensity Drug Trafficking Area (HIDTA), and the Federal Bureau of Investigation (FBI), whom he relies on for support of his research.  Dr. Sterner has excellent relationships with the National Institute of Justice, and has been successful in receiving over $2.2M in grant funding across three projects to address drug trafficking and markets, specifically with an emphasis on opioids.  Dr. Sterner is dedicated to a collaborative criminal justice approach to addressing key issues associated with drug markets, sales, trafficking, and use, and he actively works across agencies and organizations to promote this ethos in his research and outreach endeavors. Dr. Sterner has worked extensively with the Independence Blue Cross Foundation, the Department of Drug and Alcohol Programs, and Mental Health Partnerships to address stigma associated with the opioid epidemic, coordinating the Share Your Opioid Story initiative, which has helped to highlight the depth and breadth of this issue in our communities through qualitative story telling.  Through this work, he has provided the opportunity to open up the conversation on stigma, helping to ensure that all individuals associated with the opioid epidemic are supported in our communities, rural to urban. This partnership between Penn State University, Independence Blue Cross Foundation, the Pennsylvania Department of Drug and Alcohol Programs, and Mental Health Partnerships has been recognized by the Pennsylvania Business Journal through their Faces of Philanthropy.  For his work on the opioid epidemic, Dr. Sterner has been recognized by the Independence Blue Cross Foundation as a Future Leader of Community Health.  He received the 2019 Penn State Community Engagement and Scholarship Award for the impact the Share Your Opioid Story Initiative is having in our communities, and in 2020 was recognized by the University for his engaged scholarly activity. In addition to his extensive work on the opioid epidemic, he is also actively engaged in research on the networks of human sex trafficking. He is a dedicated scholar in community engagement. He is also actively engaged in research to improve learning for students in higher education.  He received his PhD from The Pennsylvania State University in Rural Sociology, and an M.A. and B.S. from Michigan State University.

                • Alan H.B. Wu, PhD, DABACC
                  Chief of Clinical Chemistry and Toxicology Medical Director, Pharmacogenomics Laboratory San Francisco General Hospital Professor of Laboratory Medicine, USF
                  Biography

                    Alan H.B. Wu, Ph.D., DABACC, is Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital Professor of Laboratory Medicine, University of California, San Francisco, and medical director for the Pharmacogenomics Laboratory.  He received B.S. degrees in chemistry and biology at Purdue University, West Lafayette, Indiana, and a Ph.D. degree in analytical chemistry at the University of Illinois, Champaign-Urbana, Illinois.  He completed a postdoctoral fellowship in clinical chemistry at Hartford Hospital.  He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry. His research interests include pharmacogenomics, clinical toxicology, cardiac biomarkers, and point-of-care testing.  Dr. Wu has over 400 publications in peer-reviewed journals.  He has also written five paperback books consisting of short stories designed to promote the value of the clinical laboratory and pharmacogenomics to the general public.

                  Sponsored by

                  For information on becoming a sponsor or exhibitor, please click here.


                  C.E. Credits

                  The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                  Help

                  General LabRoots Questions

                  email support@labroots.com  

                  Virtual Events and Webinars

                  Supported Configurations

                  • Operating System Internet Explorer Firefox Chrome Safari
                    Vista IE8+ FF10+ Chrome15+
                    Windows 7 IE8+ FF10+ Chrome15+
                    Windows 8 IE10 FF10+ Chrome15+
                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                  • Cookie settings: session cookies enabled
                  • Browser configuration must have JavaScript enabled
                  • Adobe Flash player 10.2 or later

                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                  Internet Connection

                  • A minimum of 100Kbps is recommended for audio-only events
                  • A minimum of 300Kbps is recommended for speaker on-video events

                  Computer Equipment

                  • Screen Resolution: Minimum 1024x768
                  • Video Card: 65,000 colors minimum
                  • Sound card and speakers (or headphones) for hearing webcast in full format
                  • Audio Card: 16-bit minimum
                  • RAM: 512MB of free RAM

                  Firewall Protocol

                  • HTTP on port 80 or HTTPS on port 443
                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                  Work-At-Home Attendees

                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                  For A Seamless Experience

                  When using a mobile device, FREE Mobile Apps are available:

                  - For viewing Webinars:

                  - For viewing Virtual Events

                  Attendee Guide

                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                  Virtual Event and Webinar Support:

                  Continuing Education (CME/CE) Support

                  Loading Comments...
                  Show Resources
                  Event Countdown
                  • 0 Days
                  • 0 Hours
                  • 0 Minutes
                  • 0 Seconds
                  Attendees
                  • See more